PERSPECTA

News from every angle

Back to headlines

Iovance Biotherapeutics (IOVA) Announces Positive Early Data for Lifileucel TIL Therapy in Advanced Sarcomas

14 Mar, 10:22 — 14 Mar, 10:22
PostShare

Sources

Showing 1 of 1 sources